Poznanski EO, Mokros HB: Manual for the Children’s Depression Rating Scale—Revised. Los Angeles, Western Psychological Services, 1995
Â
Reynolds WM: Suicidal Ideation Questionnaire: Professional Manual. Lutz, Fla, Psychological Assessment Resources, Inc, 1991
Â
Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007; 164:1035—1043
Â
Bridge JA, Goldstein TR, Brent DA: Adolescent suicide and suicidal behavior. J Child Psychol Psychiatry 2006; 47:372—394
Â
Eaton DK, Kann L, Kinchen S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Shanklin S, Lim C, Grunbaum JA, Wechsler H: Youth Risk Behavior Surveillance: United States, 2005. J Sch Health 2006; 76:353—372
Â
Swahn MH, Bossarte RM: Gender, early alcohol use, and suicide ideation and attempts: findings from the 2005 Youth Risk Behavior Survey. J Adolesc Health 2007; 41:175—181
Â
Centers for Disease Control and Prevention: 2004 United States Suicide Injury Deaths and Rates. Atlanta, National Center for Injury Prevention and Control, 2007 (http://webappa.cdc.gov/sasweb/ncipc/mortrate10_sy.html)
Â
Brent DA, Kolko DJ, Wartella ME, Boylan MB, Moritz G, Baugher M, Zelenak JP: Adolescent psychiatric inpatients’ risk of suicide attempt at 6-month follow-up. J Am Acad Child Adolesc Psychiatry 1993; 32:95—105
Â
Goldston DB, Daniel SS, Reboussin BA, Reboussin DM, Kelley AE, Frazier PH: Psychiatric diagnoses of previous suicide attempters, first-time attempters, and repeat attempters on an adolescent inpatient psychiatric unit. J Am Acad Child Adolesc Psychiatry 1998; 37:924—932
Â
Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory M: Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996; 53:339—348
Â
Gould MS, Greenberg T, Velting DM, Shaffer D: Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003; 42:386—405
Â
Ashworth J: Practice Principles: A Guide for Mental Health Clinicians Working With Suicidal Children and Youth. Vancouver, Ministry of Children and Family Development, British Columbia, 2001. http://www.mcf.gov.bc.ca/mental_health/pdf/suicid_prev_manual.pdf
Â
Beck AT, Kovacs M, Weissman M: Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47:343—352
Â
Spirito A, Boergers J, Donaldson D, Bishop D, Lewander W: An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. J Am Acad Child Adolesc Psychiatry 2002; 41:435—442
Â
Weisz JR, McCarthy CA, Valeri SM: Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006; 132:132—149
Â
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297:1683—1696
Â
Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63:332—339
Â
Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM: A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 2004; 61:577—584
Â
19.
Brent D, Poling K: Cognitive Therapy Treatment Manual for Depressed and Suicidal Youth. Pittsburgh, Star Center, 1997
Â
Curry JF, Wells KC: Striving for effectiveness in the treatment of adolescent depression: cognitive behavior therapy for multisite community intervention. Cogn Behav Pract 2005; 12:177—185
Â
The TADS Team: Fluoxetine, cognitive behavior therapy, and their combination for adolescents with depression. JAMA 2004; 292:807—820
Â
Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J; TADS Team: Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1404—1411
Â
Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robins M, March J; TADS Team: Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1419—1426
Â
Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R: Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behavior therapy in adolescents with major depression: randomized controlled trial. BMJ 2007; 335:142—149
Â
Goodman WK, Murphy TK, Storch EA: Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl) 2007; 191:87—96
Â
US Food and Drug Administration: Antidepressant Use in Children, Adolescents, and Adults: Revisions to Product Labeling. http://www.fda.gov/cder/drug/antidepressants/antidepressants_label_change_2007.pdf
Â
Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ: Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007; 164:884—891
Â
Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RMC, Mann JJ: Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164:1356—1363
Â
The TADS Team: The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007; 64:1132—1144
Â
Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT: Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005; 294:563—570
Â
Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy versus therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006; 63:757—766
Â
Brunstein Klomek A, Stanley B: Psychosocial treatment of depression and suicidality in adolescents. CNS Spectr 2007; 12:135—144
Â
Morrato EH, Libby AM, Orton HD, deGruy FV III, Brent DA, Allen R, Valuck RJ: Frequency of provider contact after FDA advisory on suicidal risk of pediatric suicidality with SSRIs. Am J Psychiatry 2008; 165:42—50
Â
Bhatia S, Rezac AJ, Vitiello B, Sitorius MA, Buehler BA, Kratochvil CJ: Antidepressant prescribing practices for the treatment of children and adolescents. J Child Adolesc Psychopharmacology (in press)
Â
US Food and Drug Administration: Revision to Medication Guide: Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions. Revised May 2, 2007. http://www.fda.gov/cder/drug/antidepressants/antidepressants_MG_2007.pdf
Â